President Donald Trump's executive order reclassifying cannabis as a Schedule 3 drug could come Monday - and with it, Medicare coverage for CBD.
Bombshell cannabis study reveals hidden risks of medical pot that may actually outweigh any benefits
The review also found that daily use of medical cannabis — especially inhaled or high-potency products — may increase the ...
The 19-year-old Schaumburg woman who inspired Illinois’ Ashley’s Law in 2018 to have access to her medical marijuana patches ...
President Donald Trump is expected to direct his administration to move to reclassify marijuana as a less dangerous drug, according to people familiar with the matter, a move that could represent one ...
"Colorado's cannabis industry has been in a free-fall since 2021, and 2025 sales are trending down yet again, so operators ...
A study published in the Annals of Internal Medicine found an association between community exposure to cannabis retailers and increased rates of harm. Thi | Cannabis Sciences ...
Researchers found a chasm between the health reasons for which the public seeks out cannabis and what gold-standard science ...
As the Trump administration ponders reclassifying marijuana from a Schedule I to a Schedule III drug, this is what it means for consumers.
The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or ...
After more than 50 years of being classified as one of the most dangerous substances, marijuana may be rescheduled with fewer restrictions by the Trump admin.
Asianet Newsable on MSN
Study reveals medical cannabis has limited benefits and notable safety concerns
A review of 2,500+ studies finds medical cannabis has proven benefits for only a few conditions, while many popular claims ...
President Donald Trump has voiced support for reclassifying cannabis and making it a legally obtainable drug -- possibly as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results